4.5 Article

Hippocampal metabotropic glutamate receptor long-term depression in health and disease: focuson mitogen-activated protein kinase pathways

期刊

JOURNAL OF NEUROCHEMISTRY
卷 139, 期 -, 页码 200-214

出版社

WILEY
DOI: 10.1111/jnc.13592

关键词

Alzheimer's disease; AMPAR trafficking; ERK1; 2; Fragile X syndrome; mGluR-LTD; p38 mitogen-activated protein kinase

资金

  1. Wellcome Trust [200646/Z/16/Z] Funding Source: Wellcome Trust
  2. BBSRC [BB/H018344/1, BB/K019899/1] Funding Source: UKRI
  3. MRC [MR/K023098/1] Funding Source: UKRI
  4. Biotechnology and Biological Sciences Research Council [BB/H018344/1, BB/K019899/1] Funding Source: Medline
  5. Medical Research Council [MR/K023098/1] Funding Source: Medline
  6. Wellcome Trust [200646/Z/16/Z] Funding Source: Medline
  7. Biotechnology and Biological Sciences Research Council [BB/K019899/1, BB/H018344/1] Funding Source: researchfish
  8. Medical Research Council [MR/K023098/1] Funding Source: researchfish

向作者/读者索取更多资源

Group I metabotropic glutamate receptor (mGluR) dependent long-term depression (LTD) is a major form of synaptic plasticity underlying learning and memory. The molecular mechanisms involved in mGluR-LTD have been investigated intensively for the last two decades. In this 60th anniversary special issue article, we review the recent advances in determining the mechanisms that regulate the induction, transduction and expression of mGluR-LTD in the hippocampus, with a focus on the mitogen-activated protein kinase (MAPK) pathways. In particular we discuss the requirement of p38 MAPK and extracellular signal-regulated kinase 1/2 (ERK 1/2) activation. The recent advances in understanding the signaling cascades regulating mGluR-LTD are then related to the cognitive impairments observed in neurological disorders, such as fragile X syndrome and Alzheimer's disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据